| 000 | 01793 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517181212.0 | ||
| 264 | 0 | _c20180924 | |
| 008 | 201809s 0 0 eng d | ||
| 022 | _a1474-547X | ||
| 024 | 7 |
_a10.1016/S0140-6736(17)32346-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGreen, Ari J | |
| 245 | 0 | 0 |
_aClemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cDec 2017 |
||
| 300 |
_a2481-2489 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aClemastine _xtherapeutic use |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aEvoked Potentials, Visual _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
| 650 | 0 | 4 |
_aRemyelination _xdrug effects |
| 650 | 0 | 4 | _aTomography, Optical Coherence |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGelfand, Jeffrey M | |
| 700 | 1 | _aCree, Bruce A | |
| 700 | 1 | _aBevan, Carolyn | |
| 700 | 1 | _aBoscardin, W John | |
| 700 | 1 | _aMei, Feng | |
| 700 | 1 | _aInman, Justin | |
| 700 | 1 | _aArnow, Sam | |
| 700 | 1 | _aDevereux, Michael | |
| 700 | 1 | _aAbounasr, Aya | |
| 700 | 1 | _aNobuta, Hiroko | |
| 700 | 1 | _aZhu, Alyssa | |
| 700 | 1 | _aFriessen, Matt | |
| 700 | 1 | _aGerona, Roy | |
| 700 | 1 | _avon Büdingen, Hans Christian | |
| 700 | 1 | _aHenry, Roland G | |
| 700 | 1 | _aHauser, Stephen L | |
| 700 | 1 | _aChan, Jonah R | |
| 773 | 0 |
_tLancet (London, England) _gvol. 390 _gno. 10111 _gp. 2481-2489 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(17)32346-2 _zAvailable from publisher's website |
| 999 |
_c27682675 _d27682675 |
||